Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grand Pharmaceutical GroupCGPHF 88 3-Year Share Buyback Ratio is 0.50 as of Dec. 2025. GuruFocus rates CGPHF with a GF Score™ of 88/100. The stock has 6 warning signs investors should review. Among 646 Drug Manufacturers companies, Grand Pharmaceutical Group ranks better than 85.91% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Grand Pharmaceutical Group's current 3-Year Share Buyback Ratio was 0.50%.
The historical rank and industry rank for Grand Pharmaceutical Group's 3-Year Share Buyback Ratio or its related term are showing as below:
CGPHF'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -75.3 Med: -4.2 Max: 0.5
Current: 0.5
During the past 13 years, Grand Pharmaceutical Group's highest 3-Year Share Buyback Ratio was 0.50%. The lowest was -75.30%. And the median was -4.20%.
CGPHF's 3-Year Share Buyback Ratio is ranked better than 85.91% of 646
companies
in the Drug Manufacturers industry
Industry Median: -2.1
vs CGPHF: 0.50
Grand Pharmaceutical Group (OTCPK:CGPHF) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Grand Pharmaceutical Group 3-Year Share Buyback Ratio Related Terms
CGPHF vs ZTS: 3-Year Share Buyback Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Pharmaceutical Group 3-Year Share Buyback Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Grand Pharmaceutical Group's 3-Year Share Buyback Ratio falls into.
Grand Pharmaceutical Group 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.50 mean?
Grand Pharmaceutical Group (CGPHF) has a 3-Year Share Buyback Ratio of 0.50 as of Dec. 2025. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Grand Pharmaceutical Group and its competitors. According to the industry distribution chart, Grand Pharmaceutical Group ranks #91 out of 646 companies in the Drug Manufacturers industry, placing it in the top 14.1%.
Is Grand Pharmaceutical Group's 3-Year Share Buyback Ratio too high?
Grand Pharmaceutical Group's current 3-Year Share Buyback Ratio is 0.50. Based on the distribution chart, Grand Pharmaceutical Group ranks #91 out of 646 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grand Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's 3-Year Share Buyback Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #91 out of 646 companies for 3-Year Share Buyback Ratio. This places Grand Pharmaceutical Group in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Year Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Grand Pharmaceutical Group and its competitors. Grand Pharmaceutical Group's current 3-Year Share Buyback Ratio is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current 3-Year Share Buyback Ratio of 0.50. The current 3-Year Share Buyback Ratio is 0.50. Grand Pharmaceutical Group's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current 3-Year Share Buyback Ratio is 0.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGPHF has been successfully added to your 
